Monday, December 30, 2013 5:25:23 PM
December 23, 2013
DNA Sequencing: Zero-Mode Waveguides Turn 10
Analytical devices allow researchers to track the sequencing of long, continuous stretches of DNA
A decade ago, researchers at Cornell University reported an analytical device, which they called a zero-mode waveguide, for using light to detect single biomolecules in samples of any concentration. That device was remarkably simple—just an array of nanometer-scale holes in a metal film on a fused-silica surface (Science 2003, DOI: 10.1126/science.1079700). Today, that unpretentious device is the basis of the DNA-sequencing technology from Pacific Biosciences, based in Menlo Park, Calif.
Waveguides are devices that are used to direct light and sound waves—optical fibers are one example. Zero-mode waveguides are so named because the holes, which serve as the waveguides, are smaller than the wavelength of light used, so the light doesn’t pass through the holes.
From the beginning, the Cornell team’s waveguides were intended to be used for optically monitoring the progress of DNA sequencing. “We knew the fundamental limitation in fluorescence-based sequencing would be background noise caused by other nucleotides,” says Stephen W. Turner, founder and chief technology officer of Pacific Biosciences, who was on the team that invented the zero-mode waveguides. “We needed to reduce the observation volume.”
Turner and his Cornell colleagues tried several approaches. “Most of them worked to some degree, but the zero-mode waveguide worked so well and was so much better and simpler than the others that it was the hands-down winner,” Turner says. The technology is now the heart of Pacific Biosciences’ PacBio RS II sequencing instrument.
Each waveguide in a disposable PacBio RS II reaction cell serves as a tiny vessel for a DNA-sequencing reaction. Single polymerase enzymes are immobilized in a waveguide, which provides a window to observe sequencing in real time by precisely following the incorporation of fluorescently labeled nucleotides. The prototype device had a few thousand waveguides, but today’s PacBio RS II uses reaction vessels with 150,000 waveguides that can be monitored simultaneously. The combination of the waveguide and specially designed DNA polymerases allows sequence read lengths that are thousands of base pairs long—some longer than 30,000 base pairs, which is the most among DNA sequencers.
Other sequencing devices sometimes have trouble working through DNA regions containing a lot of guanine and cytosine (GC) bases, but not the PacBio RS II. “The place where PacBio is truly amazing is its lack of GC bias,” comments Jay Shendure, associate professor of genome sciences at the University of Washington. “That, along with the long read lengths, is enabling its utility in niche applications such as accurate assembly of microbial genomes with high or low GC content, as well as accurate assembly of challenging regions of mammalian genomes.”
http://cen.acs.org/articles/91/i51/DNA-Sequencing-Zero-Mode-Waveguides.html?utm_content=bufferd3df9&utm_source=buffer&utm_medium=twitter&utm_campaign=Buffer
Recent PACB News
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:17:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:07:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:17:12 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM